Influence of clinical immunosuppression on proinflammatory cytokines and acute-phase proteins.
Semenkov
V F
VF
Research Institute of Gerontology, Russian Ministry of Health, Moscow, Russia.
Artemjeva
O V
OV
Shishina
R N
RN
Golubeva
V L
VL
Serova
L D
LD
D000209:Acute-Phase Proteins / Q000032:analysis / Q000378:metabolism*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood*; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D012016:Reference Values
D000209:Acute-Phase Proteins; D000961:Antilymphocyte Serum; D016207:Cytokines; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D008775:Methylprednisolone